Jiong Wu

2.3k total citations · 2 hit papers
23 papers, 1.4k citations indexed

About

Jiong Wu is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiong Wu has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiong Wu's work include Breast Cancer Treatment Studies (7 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). Jiong Wu is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (5 papers). Jiong Wu collaborates with scholars based in China, United States and Australia. Jiong Wu's co-authors include Fang Zheng, Dajing Guo, Linli Chen, Kunhua Li, WU Fa-qi, Chuanming Li, Chuanming Li, Xiaojia Wu, Huizhe Huang and Wenbing Zeng and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Molecular Therapy.

In The Last Decade

Jiong Wu

19 papers receiving 1.4k citations

Hit Papers

The Clinical and Chest CT... 2020 2026 2022 2024 2020 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia
    2020 849 citations Kunhua Li, Jiong Wu et al. Investigative Radiology profile →
  2. Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features
    2020 425 citations Jiong Wu, Xiaojia Wu et al. Investigative Radiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiong Wu China 7 897 674 427 313 178 23 1.4k
Fang Zheng China 11 1.0k 1.2× 930 1.4× 473 1.1× 332 1.1× 209 1.2× 25 1.7k
Scott Simpson United States 12 713 0.8× 699 1.0× 228 0.5× 323 1.0× 269 1.5× 32 1.4k
Sana Salehi United States 12 691 0.8× 819 1.2× 264 0.6× 242 0.8× 230 1.3× 25 1.5k
Tingting Zhu China 9 904 1.0× 815 1.2× 358 0.8× 237 0.8× 197 1.1× 21 1.5k
Kunhua Li China 7 591 0.7× 446 0.7× 314 0.7× 208 0.7× 107 0.6× 16 1.0k
Shuchang Zhou China 9 946 1.1× 865 1.3× 350 0.8× 278 0.9× 214 1.2× 17 1.5k
Meiyan Liao China 17 774 0.9× 332 0.5× 443 1.0× 257 0.8× 86 0.5× 64 1.5k
Marie‐Pierre Revel France 18 516 0.6× 652 1.0× 241 0.6× 258 0.8× 187 1.1× 43 1.5k
Hanxiong Guan China 9 818 0.9× 503 0.7× 352 0.8× 186 0.6× 113 0.6× 24 1.2k
Wenjian Xu China 10 1.1k 1.2× 1.4k 2.1× 394 0.9× 323 1.0× 240 1.3× 17 2.2k

Countries citing papers authored by Jiong Wu

Since Specialization
Citations

This map shows the geographic impact of Jiong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiong Wu more than expected).

Fields of papers citing papers by Jiong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiong Wu. The network helps show where Jiong Wu may publish in the future.

Co-authorship network of co-authors of Jiong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiong Wu. A scholar is included among the top collaborators of Jiong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiong Wu. Jiong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Li, Wenya Wu, Fei Liang, et al.. (2025). A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2‐ breast cancer‐FINEST study. Cancer Communications. 45(4). 411–421. 3 indexed citations
2.
Chen, Li, Shan Jiang, Guang‐Yu Liu, et al.. (2025). CD8-guided immunochemotherapy improves pathological complete response rates in high-tumor-burden triple-negative breast cancer. Molecular Therapy. 34(2). 885–897.
3.
4.
Wu, Jiong, Jian Zhang, Man Li, et al.. (2024). A phase Ib study of PI3Kα inhibitor risovalisib mesylate in combination with fulvestrant in patients with PIK3CA-mutated, HR+/HER2- advanced breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1047–1047. 1 indexed citations
5.
6.
Liu, Jian, Cong Chen, Honggang Chen, et al.. (2024). Patient-Reported Outcomes and Complication Profiles of Implant-Based Breast Reconstruction in Patients With Postmastectomy Radiation Therapy. Annals of Plastic Surgery. 93(1). 22–29. 2 indexed citations
7.
Chen, Jiajian, Shuang Hao, Bingqiu Xiu, et al.. (2023). Abstract P1-05-31: A single center retrospective analysis of 259 cases of metaplastic breast cancer. Cancer Research. 83(5_Supplement). P1–5. 1 indexed citations
8.
9.
Sang, Yuting, Jiajian Chen, Benlong Yang, et al.. (2023). Abstract P2-14-02: Surgical options of the breast and clinical outcomes in breast cancer patients after neoadjuvant chemotherapy: a single-center retrospective study. Cancer Research. 83(5_Supplement). P2–14. 1 indexed citations
10.
Wu, Jiong, Benlong Yang, Mingliang Zhang, et al.. (2023). Abstract OT2-16-04: KN026 in combination with docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer: A single arm, multicenter, phase 2 study. Cancer Research. 83(5_Supplement). OT2–16. 1 indexed citations
11.
Chen, Ming, et al.. (2022). The Prognostic Values of Androgen Receptor in Breast Cancer. Archives of Pathology & Laboratory Medicine. 147(9). 1075–1085. 3 indexed citations
12.
Li, Jianbin, Xiaojia Wang, Shusen Wang, et al.. (2022). Expert consensus on the clinical diagnosis and targeted therapy of HER2 breast cancer (2023 edition). PubMed. 3. 30–30. 5 indexed citations
13.
14.
Li, Kunhua, Jiong Wu, WU Fa-qi, et al.. (2020). The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. Investigative Radiology. 55(6). 327–331. 849 indexed citations breakdown →
15.
Wu, Jiong, Xiaojia Wu, Wenbing Zeng, et al.. (2020). Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features. Investigative Radiology. 55(5). 257–261. 425 indexed citations breakdown →
16.
Fu, Yi, et al.. (2016). Assessment of fibrotic tissue and microvascular architecture by in-line phase-contrast imaging in a mouse model of liver fibrosis. European Radiology. 26(9). 2947–2955. 13 indexed citations
17.
Huang, Naisi, Mengying Liu, Peirong Yu, & Jiong Wu. (2015). Antibiotic prophylaxis in prosthesis-based mammoplasty: A systematic review. International Journal of Surgery. 15. 31–37. 30 indexed citations
18.
Chen, Ying, Zhenzhou Shen, Zhimin Shao, Peirong Yu, & Jiong Wu. (2015). Free Flap Monitoring Using Near-Infrared Spectroscopy. Annals of Plastic Surgery. 76(5). 590–597. 61 indexed citations
19.
Chen, Ying, Jiajian Chen, Jiaying Chen, et al.. (2014). [Current trends of breast reconstruction after mastectomy for breast cancer patients in China: a survey report].. PubMed. 36(11). 851–7. 12 indexed citations
20.
Wu, Jiong, et al.. (2014). Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China. OncoTargets and Therapy. 7. 2147–2147. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fang Zheng Breakdown of academic impact, for papers by Scott Simpson Breakdown of academic impact, for papers by Sana Salehi Breakdown of academic impact, for papers by Tingting Zhu Breakdown of academic impact, for papers by Kunhua Li Breakdown of academic impact, for papers by Shuchang Zhou Breakdown of academic impact, for papers by Meiyan Liao Breakdown of academic impact, for papers by Marie‐Pierre Revel Breakdown of academic impact, for papers by Hanxiong Guan Breakdown of academic impact, for papers by Wenjian Xu
Rankless by CCL
2026